Ionis Pharmaceuticals (IONS) Other Operating Expenses (2010 - 2026)

Ionis Pharmaceuticals' Other Operating Expenses history runs 13 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 103.9% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $17.4 million (up 65.56% YoY), while the FY2025 annual figure was $15.9 million, up 132675.0% from the prior year.
• Other Operating Expenses was $3.0 million for Q1 2026 at Ionis Pharmaceuticals, down from $8.0 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $756.8 million in Q4 2022 to a low of $1.1 million in Q3 2024.
• Historically, Other Operating Expenses has averaged $47.4 million across 5 years, with a median of $3.0 million in 2026.
• The sharpest annual moves came in 2023 and 2025: Other Operating Expenses slumped 99.6% in 2023, then surged 118.3% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at $756.8 million in 2022, then plunged by 99.6% to $3.1 million in 2023, then gained by 25.09% to $3.8 million in 2024, then soared by 107.81% to $8.0 million in 2025, then plunged by 62.51% to $3.0 million in 2026.
• The last three Other Operating Expenses figures came in at $3.0 million (Q1 2026), $8.0 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.